Abstract
Neurotrophin 3 (NT-3) is a member of the neurotrophin gene family which supports the survival of specific neurons. NT-3 was shown to prevent the death of adult central noradrenergic neurons in vivo, a neuronal population which is associated with the pathophysiology of major depression. We quantitated CSF levels of NT-3 in elderly patients with major depression (DE) and compared them to patients with Alzheimer's disease (AD), and mentally healthy control subjects (CTR). CSF levels of NT-3 were markedly and significantly elevated in the DE group, as compared to either the AD or the CTR group (P < 0.01, and P < 0.001, respectively). in terms of diagnostic accuracy, measurement of nt-3 levels in de resulted in 73.9% sensitivity, and 89.7% specificity. increased csf levels of nt-3 may indicate a disturbance of the central noradrenergic system in patients with de. nt-3 may constitute a biochemical candidate marker for clinical diagnosis and for the evaluation of therapeutic strategies in de.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study
Translational Psychiatry Open Access 21 May 2020
-
The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections
Journal of Neural Transmission Open Access 14 February 2019
-
2D-DIGE proteome analysis on the platelet proteins of patients with major depression
Proteome Science Open Access 03 January 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout


References
Bothwell M . Functional interactions of neurotrophins and neurotrophin receptors Annu Rev Neurosci 1995; 18: 223–253
Price DL, Tanzi RE, Borchelt DR, Sisodia SS . Alzheimer's disease: genetic studies and transgenic models Annu Rev Genet 1998; 32: 461–493
Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra Nature 1991; 350: 230–232
Knüsel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, Nicolics K et al. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3 Proc Natl Acad Sci USA 1991; 88: 961–965
Mamounas LA, Blue ME, Siuciak JA, Altar CA . Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain J Neurosci 1995; 15: 7929–7939
Arenas E, Persson H . Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo Nature 1994; 367: 368–371
Leonard BE . The role of noradrenaline in depression: a review J Psychopharmacol 1997; 11: S39–S47
Gall CM, Gold SJ, Isackson PJ, Seroogy KB . Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons Mol Cell Neurosci 1992; 3: 56–63
Lindholm D, Hamner S, Zirrgiebel U . Neurotrophins and cerebellar development Perspect Dev Neurobiol 1997; 5: 83–94
Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay RM et al. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF Science 1990; 247: 1146–1451
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlau EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 1984; 34: 939–944
Folstein MF, Folstein SE, McHugh PR . Mini Mental State. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 1975; 12: 189–198
Spiegel R, Brunner C, Ermini-Funfschilling D, Monsch A, Notter M, Puxty J et al. A new behavioral assessment scale for geriatric out- and in-patients: the NOSGER (Nurses’ Observation Scale for Geriatric Patients) J Am Geriatr Soc 1991; 39: 339–347
Montgomery SA, Asberg M . A new depression scale designed to be sensitive to change Br J Psychiatry 1979; 134: 382–389
McDowell IF, Wisdom GB, Trimble ER . Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting Clin Chem 1989; 35: 2070–2073
Hansen PS, Gerdes LU, Klausen IC, Gregersen N, Faergeman O . Genotyping compared with protein phenotyping of the common apolipoprotein E polymorphism Clin Chim Acta 1994; 224: 131–137
Leonard BE . The role of noradrenaline in depression: a review J Psychopharmacol 1997; 11: S39–S47
Gilmore JH, Jarskog LF, Lindgren JC, McEvoy JP, Xiao H . Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness Psychiatry Res 1997; 73: 109–113
Murase K, Igarashi K, Hayashi K . Neurotrophin-3 (NT-3) levels in the developing rat nervous system and in human samples Clin Chim Acta 1994; 227: 23–36
Kunugi H, Hattori M, Ueki A, Isse K, Hirasawa H, Nanko S . Possible association of missense mutation (Gly[-63]Glu) of the neurotrophin-3 gene with Alzheimer's disease in Japanese Neurosci Lett 1998; 241: 65–67
Smith MA, Makino S, Altemus M, Michelson D, Hong SK, Kvetnansky R et al. Stress and antidepressants differentially regulate neurotrophin 3mRNA expression in the locus coeruleus Proc Natl Acad Sci USA 1995; 92: 8788–8792
Nibuya M, Morinobu S, Duman RS . Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J Neurosci 1995; 15: 7539–7547
Duman RS, Heninger GR, Nestler EJ . A molecular and cellular theory of depression Arch Gen Psychiatry 1997; 54: 597–606
Altar CA . Neurotrophins and depression Trends Pharmacol Sci 1999; 20: 59–61
Acknowledgements
This work was supported by Grants 3100–049397.96/1 (Schweizerischer Nationalfonds) (UO, CH, FM-S), and SFB505 (Deutsche Forschungsgemeinschaft) (UO). We thank F Jancu for technical support and K Kräuchi, PhD, for help in statistical analyses.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hock, C., Heese, K., Müller-Spahn, F. et al. Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression. Mol Psychiatry 5, 510–513 (2000). https://doi.org/10.1038/sj.mp.4000743
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000743
Keywords
- noradrenaline
- basal forebrain
- neurotrophins
- ELISA
- aging
This article is cited by
-
Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study
Translational Psychiatry (2020)
-
The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections
Journal of Neural Transmission (2019)
-
Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis
Molecular Psychiatry (2016)
-
2D-DIGE proteome analysis on the platelet proteins of patients with major depression
Proteome Science (2014)
-
Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression?
BMC Neuroscience (2012)